OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The “Yin and Yang” of Natural Compounds in Anticancer Therapy of Triple-Negative Breast Cancers
Elizabeth Varghese, Samson Mathews Samuel, Mariam Abotaleb, et al.
Cancers (2018) Vol. 10, Iss. 10, pp. 346-346
Open Access | Times Cited: 94

Showing 26-50 of 94 citing articles:

Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study
Lakshya Mittal, Uma K. Aryal, Ignacio G. Camarillo, et al.
Bioelectrochemistry (2019) Vol. 131, pp. 107350-107350
Closed Access | Times Cited: 42

Lemon Balm Extracts Prevent Breast Cancer Progression In Vitro and In Ovo on Chorioallantoic Membrane Assay
Roxana Ghiulai, Ștefana Avram, Dana Stoian, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 39

Comparative anticancer activities of Ficus carica and Ficus salicifolia latex in MDA-MB-231 cells
Fatma Mousa AlGhalban, Amir Ali Khan, Muhammad Nasir Khan Khattak
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 6, pp. 3225-3234
Open Access | Times Cited: 34

Phytochemicals in cancer and their effect on the PI3K/AKT-mediated cellular signalling
Olaf‐Georg Issinger, Bárbara Guerra
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111650-111650
Open Access | Times Cited: 33

New Achievements for the Treatment of Triple-Negative Breast Cancer
Alessia Catalano, Domenico Iacopetta, Jessica Ceramella, et al.
Applied Sciences (2022) Vol. 12, Iss. 11, pp. 5554-5554
Open Access | Times Cited: 23

Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 23

Discovery of Pyrimidine- and Coumarin-Linked Hybrid Molecules as Inducers of JNK Phosphorylation through ROS Generation in Breast Cancer Cells
Na Young Kim, Divakar Vishwanath, Xi Zhang, et al.
Molecules (2023) Vol. 28, Iss. 8, pp. 3450-3450
Open Access | Times Cited: 13

Phytocompounds and Nanoformulations for Anticancer Therapy: A Review
Giuseppina Bozzuto, Annarica Calcabrini, Marisa Colone, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3784-3784
Open Access | Times Cited: 4

Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2482-2482
Open Access | Times Cited: 38

Implications of flavonoids as potential modulators of cancer neovascularity
Alena Líšková, Lenka Koklesová, Marek Samec, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 12, pp. 3079-3096
Closed Access | Times Cited: 38

Antiproliferative Effect of Acridine Chalcone Is Mediated by Induction of Oxidative Stress
Peter Takáč, Martin Kello, Mária Vilková, et al.
Biomolecules (2020) Vol. 10, Iss. 2, pp. 345-345
Open Access | Times Cited: 37

Recent progress in small molecule agents for the targeted therapy of triple-negative breast cancer
Rajibul Islam, Kok Wai Lam
European Journal of Medicinal Chemistry (2020) Vol. 207, pp. 112812-112812
Closed Access | Times Cited: 37

Tumor microenvironment pathways: Cross regulation in breast cancer metastasis
Rama Rao Malla, P. Janardhana Kiran
Genes & Diseases (2020) Vol. 9, Iss. 2, pp. 310-324
Open Access | Times Cited: 35

Insulin Resistance in Osteoarthritis: Similar Mechanisms to Type 2 Diabetes Mellitus
Elena V. Tchetina, Galina A. Markova, Е. П. Шарапова
Journal of Nutrition and Metabolism (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 34

A Review of Twenty Years of Research on the Regulation of Signaling Pathways by Natural Products in Breast Cancer
Muhammad Naeem, Muhammad Omer Iqbal, Humaira Khan, et al.
Molecules (2022) Vol. 27, Iss. 11, pp. 3412-3412
Open Access | Times Cited: 18

Two Natural Alkaloids Synergistically Induce Apoptosis in Breast Cancer Cells by Inhibiting STAT3 Activation
Di Chen, Yangmin Ma, Zhiyu Guo, et al.
Molecules (2020) Vol. 25, Iss. 1, pp. 216-216
Open Access | Times Cited: 31

Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer
Samia S. Messeha, Najla O. Zarmouh, Karam F. A. Soliman
Nutrients (2021) Vol. 13, Iss. 5, pp. 1718-1718
Open Access | Times Cited: 23

Sophoraflavanone G suppresses the progression of triple‐negative breast cancer via the inactivation of EGFR–PI3K–AKT signaling
Wei Cheng, Dan Liu, Min Guo, et al.
Drug Development Research (2022) Vol. 83, Iss. 5, pp. 1138-1151
Closed Access | Times Cited: 16

Triptolide Decreases Cell Proliferation and Induces Cell Death in Triple Negative MDA-MB-231 Breast Cancer Cells
Elizabeth Varghese, Samson Mathews Samuel, Sharon Varghese, et al.
Biomolecules (2018) Vol. 8, Iss. 4, pp. 163-163
Open Access | Times Cited: 30

Antifungal, Antitumoral and Antioxidant Potential of the Danube Delta Nymphaea alba Extracts
Mihaela Cudălbeanu, Bianca Furdui, Geta Cârâc, et al.
Antibiotics (2019) Vol. 9, Iss. 1, pp. 7-7
Open Access | Times Cited: 26

Cytotoxicity of Seaweed Compounds, Alone or Combined to Reference Drugs, against Breast Cell Lines Cultured in 2D and 3D
Fernanda Malhão, Alice A. Ramos, Ana Catarina Macedo, et al.
Toxics (2021) Vol. 9, Iss. 2, pp. 24-24
Open Access | Times Cited: 21

Joint Transcriptomic and Metabolic Analysis of Flavonoids in Cyclocarya paliurus Leaves
Xiaoling Sheng, Huanwei Chen, Jianmei Wang, et al.
ACS Omega (2021) Vol. 6, Iss. 13, pp. 9028-9038
Open Access | Times Cited: 20

Ellagitannins, promising pharmacological agents for the treatment of cancer stem cells
Zohre Senobari, Gholamreza Karimi, Khadijeh Jamialahmadi
Phytotherapy Research (2021) Vol. 36, Iss. 1, pp. 231-242
Closed Access | Times Cited: 20

Multi-purpose zein nanoparticles for battling hepatocellular carcinoma: A Green approach
Essraa A. Hassan, Rania M. Hathout, Heba A. Gad, et al.
European Polymer Journal (2022) Vol. 176, pp. 111396-111396
Closed Access | Times Cited: 14

Scroll to top